QS-21 Immune Response By Keith Cohn Posted 28 September, 2015 In QS-21 Immune Response2015-09-282022-04-14https://desertking.com/wp-content/uploads/2023/04/dk-color.pngDesert Kinghttps://desertking.com/wp-content/uploads/2015/09/Pharma-1.jpg200px200px 0 Recent PostsChile Approves New Shingles Vaccine Featuring Desert King SaponinsPallerla, S., et al. Scale-up and cGMP manufacturing of next-generation vaccine adjuvant Saponin/MPLA NanoParticles (SMNP). J Pharm Sci, 2025 Jul 19, 114(9):103913.Zhou, S.H., et al. Engineered hybrid membrane vesicles combined with autologous and synthetic antigens as therapeutic vaccines to efficiently suppress tumor recurrence. J Control Release, 2025 Jun 24, 385:113979.Patel, N., et al. Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M® nanoparticle vaccine induces neutralizing responses in nonhuman primates. Nat Commun, 2025 Jul 18, 16(1):6625.
